HF
AGTC

HRT Financial’s Applied Genetic Technologies Corporation AGTC Stock Holding History

HRT Financial’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-69,536
Closed -$53K – 3799
2022
Q2 		$53K Buy
+69,536
New +$62K ﹤0.01% 2506
2021
Q4 		– Sell
-57,377
Closed -$172K – 4388
2021
Q3 		$172K Sell
57,377
-67,721
-54% -$241K ﹤0.01% 2746
2021
Q2 		$489K Buy
+125,098
New +$519K ﹤0.01% 1804

Other funds holding AGTC

PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HRT Financial's AGTC Position: Q3 2022 in Review

HRT Financial sold out of Applied Genetic Technologies Corporation (AGTC) in Q3 2022, closing a stake of 69,536 shares — an estimated $53K sold.

HRT Financial first reported a position in AGTC in Q2 2021 and held it in 3 quarters. The position peaked at $489K in Q2 2021. 45 funds tracked by Wall St. Rank hold AGTC as of Q3 2022.

  • HRT Financial reported no remaining Applied Genetic Technologies Corporation position as of Q3 2022 after selling out during the quarter.
  • HRT Financial sold 69,536 Applied Genetic Technologies Corporation shares in Q3 2022, an estimated $53K.
  • HRT Financial first reported a position in Applied Genetic Technologies Corporation in Q2 2021 and held it in 3 quarters.
  • HRT Financial's Applied Genetic Technologies Corporation position peaked at $489K in Q2 2021.
  • 45 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2022.

Based on HRT Financial's 13F filing for Q3 2022, filed 14 Nov 2022.